Screener
Discontinued — last reported Q2 '24
EBITDA at other companies
Other financials
Where this comes from
Calculated from Apyx Medical Corporation’s reported figures.
The source filing: Apyx Medical Corporation’s 10-Q, filed August 8, 2024. Open the filing →
- Filed
- Aug 8, 2024
- Fiscal quarter
- Q2 FY2024
- Calendar quarter
- Q2 2024
- Accession
- 0000719135-24-000038
FAQ
- What is Apyx Medical Corporation's EBITDA?
- Apyx Medical Corporation (APYX) reported EBITDA of -$5.39M in Q2 2024.
- How has Apyx Medical Corporation's EBITDA changed year-over-year?
- Apyx Medical Corporation's EBITDA decreased by 397.3% year-over-year, from -$1.08M to -$5.39M.
- What is the long-term trend for Apyx Medical Corporation's EBITDA?
- Over 2 years (2021 to 2023), Apyx Medical Corporation's EBITDA has grown at a 10.6% compound annual growth rate (CAGR), from -$13.55M to -$16.57M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about Apyx Medical Corporation's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude